Abstract:Background: Bladder cancer is the most common malignancy of the urinary system, and the search for new and reliable biomarkers has important clinical significance for the personalized treatment of bladder cancer. This study aims to explore the correlation between nuclear proliferation antigen (Ki-67) or Profilin-1 (PFN1) levels, clinicopathological characteristics, and postoperative prognosis in patients with bladder cancer. Methods: Patients with bladder cancer who underwent transurethral resection of bladder cancer tumor in The Fourth Affiliated Hospital of Soochow University, hospital from January 2019 to January 2021 were selected as the study group (n = 60), and patients with benign lesions of bladder cancer during the same period were selected as the control group (n = 60). The expression of Ki-67 and PFN1 in tumor and bladder tissues of the two groups was analyzed. Ki-67 recorded the patient's pathological parameters and calculated the patient's postoperative prognosis. The correlation between Ki-67 and PFN1 expression levels, pathological parameters, and postoperative prognosis was analyzed. Results: The positive expression rates of Ki-67 and PFN1 in the study group were 63.33% and 73.33%, respectively, which were significantly higher than the positive expression rates in the control group (χ2 = 14.803, 17.757, p < 0.001). The positive expression rates of Ki-67 and PFN1 were related to histological grade, clinical stage, infiltration, and lymph node metastasis, and the differences were statistically significant (p 0.05). The survival time and three-year survival rate of the Ki-67 positive expression group were significantly lower than those of the Ki-67 negative expression group (p < 0.05). The survival time and three-year survival rate of the PFN1 positive expression group were significantly lower than those of the PFN1 negative expression group (p < 0.05). Conclusion: The positive expression rates of Ki-67 and PFN1 in bladder tumor tissue are significantly higher than those in bladder tissue, and pathological pattern, histological grade, clinical stage, infiltration, and lymph node metastasis are related to the positive expression rates of Ki-67 and PFN1, and different genders, ages, tumors diameter and vascular invasion are not related to the positive expression rates of Ki-67 and PFN1. The survival time and three-year survival rates of bladder cancer patients with Ki-67 positive and PFN1 positive expression are shorter.

CORRELATION BETWEEN THE EXPRESSION LEVEL OF NUCLEAR RECEPTOR COACTIVATOR 1 AND CLINICOPATHOLOGICAL FEATURES AND PROGNOSIS IN BLADDER CANCER

The relationship of expression of p53,p21,Ki-67 and VEGF and bladder cancer stage,grade and prognosis

Expressions of cyclooxygenase-2 and epidermal growth factor receptor in transitional cell carcinoma of bladder and their correlation

Association Between Expression of Nuclear Receptor Co-Activator 5 Protein and Prognosis in Postoperative Patients with Osteosarcoma

Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy

Correlation Between the Expression of Androgen Receptor Mrna and the Long-Term Tumor-Specific and Recurrence-Free Survival Rate in Patients with T1 Bladder Cancer

NCOA5 Low Expression Correlates with Survival in Esophageal Squamous Cell Carcinoma.

Correlation between Ki-67 or Profilin-1 Expression Levels, Clinicopathological Characteristics and Postoperative Prognosis in Patients with Bladder Cancer

Nuclear Ciap1 Overexpression is a Tumor Stage- and Grade-Independent Predictor of Poor Prognosis in Human Bladder Cancer Patients

Expression of nucleosomal binding protein 1 in normal bladder mucosa and bladder cancer and its significance

NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer

High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer

Expressions Correlation of P53,vegf,cox-2 and EGFR in Bladder Cancer and Their Clinical Significance

The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.

Expression of N-cadherin Protein in Urothelial Bladder Cancer and Its Relation to Prognosis

Expression of CUGBP1 and VEGF in Bladder Cancer and Their Clinical Significance

EXPRESSION AND PROGNOSTIC EVALUATION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER

The Relationship of VEGF C Expression and Prognosis of Bladder Transitional Cell Carcinoma

Expression of MAP1A in bladder cancer and its correlation with clinicopathological features

The correlation between the expression of bladder cancer high-expressed gene BCA7 and the prognosis of bladder cancer

Expression of Long Noncoding RNA Lncrna-N336928 is Correlated with Tumor Stage and Grade and Overall Survival in Bladder Cancer.